CINECA IRIS Institutional Research Information System

Nevirapine versus atazanavir/ritonavir, each combined with tenofovir disoproxil fumarate/emtricitabine, in antiretroviral-naive HIV-1 patients: the ARTEN Trial.

DI PERRI, Giovanni;
2011-01-01
2011
ANTIVIRAL THERAPY
16
339
348
Adenine; adverse effects/analogs /&/ derivatives/therapeutic use, Adult, Anti-HIV Agents; adverse effects/therapeutic use, Cardiovascular Diseases; chemically induced/drug therapy, Deoxycytidine; adverse effects/analogs /&/ derivatives/therapeutic use, Female, HIV Infections; drug therapy/virology, HIV-1; drug effects, Humans, Male, Middle Aged, Nevirapine; adverse effects/therapeutic use, Oligopeptides; adverse effects/therapeutic use, Phosphonic Acids; adverse effects/therapeutic use, Pyridines; adverse effects/therapeutic use, Reverse Transcriptase Inhibitors; adverse effects/therapeutic use, Ritonavir; adverse effects/therapeutic use, Treatment Outcome
V. Soriano;K. Arastéh;H. Migrone;T. Lutz;M. Opravil;J. Andrade-Villanueva;F. Antunes;G. Di Perri;D. Podzamczer;S. Taylor;P. Domingo;H. Gellermann;L. d. Rossi;A. R. T.
03A-Articolo su Rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/95906
Citazioni
  • ???jsp.display-item.citation.pmc??? 23
  • Scopus 94
  • ???jsp.display-item.citation.isi??? 77
social impact